1. Academic Validation
  2. Phenylephrine promotes cardiac fibroblast proliferation through calcineurin-NFAT pathway

Phenylephrine promotes cardiac fibroblast proliferation through calcineurin-NFAT pathway

  • Front Biosci (Landmark Ed). 2016 Jan 1;21(3):502-13. doi: 10.2741/4405.
Jing Wang 1 Yibing Wang 2 Wei Zhang 3 Xi Zhao 3 Xiangfan Chen 3 Wenyan Xiao 3 Lingling Zhang 3 Yunxuan Chen 3 Weizhong Zhu 4
Affiliations

Affiliations

  • 1 Department of Pharmacy, Nantong University Affiliated Hospital, Nantong, P. R. China.
  • 2 Department of Pharmacy, Yan Cheng Institute of Health Science.
  • 3 Department of Pharmacology, Nantong University School of Pharmacy, Nantong, P. R. China.
  • 4 Department of Pharmacology, Nantong University School of Pharmacy, 19 Qi Xiu Road, Nantong, 226001, People's Republic of China, [email protected].
PMID: 26709790 DOI: 10.2741/4405
Abstract

Ca(2+)/calmodulin-dependent calcineurin (CaN) plays an important role in various Ca(+2) signaling pathways, among which are those involved in cardiac diseases. It has also been shown that a heightened sympathetic tone accelerates the development of heart failure. The present study investigates whether the CaN-mediated nuclear factor of activated T-cells (NFAT) pathway is involved in cultured neonatal rat cardiac fibroblast proliferation induced by phenylephrine. CF proliferation was assessed by a cell survival assay and cell counts. Green fluorescent protein-tagged NFAT3 was used to determine the cellular location of NFAT3. CaN activity and protein levels were also determined by an activity assay kit and Western blotting, respectively. Results showed that phenylephrine promoted CF proliferation, which was abolished by α1-adrenergic receptor antagonist (prazosin), a blocker of Ca(+2) influx (nifedipine), an intracellular Ca(2+) buffer (BAPTA-AM), CaN inhibitors (cyclosporin A and FK506), and over-expression of dominant negative CaN. Phenylephrine activated CaN and evoked NFAT3 nuclear translocation, both of which were blocked by cyclosporine A (CsA) or over-expression of dominant negative CaN. These results suggest that the Ca(2+)/CaN/NFAT pathway mediates PE-induced CF proliferation, and this pathway might be a possible therapeutic target in cardiac fibrosis.

Figures